Neuros Medical Announces Successful Pilot Study

6/29/2013

 Cleveland, OH, June 4, 2013 – Neuros Medical, Inc., a medical device company announced significant results today from their long term pilot study. The study evaluated the Company’s patented on-demand, high frequency Electrical Nerve Block technology which focused on patients afflicted with chronic amputation pain. This debilitating condition affects nearly one million patients in the U.S. alone.

Results indicated that 7 out of 9 study subjects reported significant pain reduction (defined as 50% or greater) observed for up to 12 months of evaluation. The study demonstrated no safety issues over the treatment period. Study subjects reported an average pain score reduction of 6 to 1 (an 83% pain reduction) based on a 0 to 10 Numerical Rating Scale. Significant pain reduction was reported in 91% of all treatment sessions. In addition, more than half of the subjects discontinued their narcotic pain medication use during the study.